Licensure: Clinical Trials

4 trials of Licensure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 2 Phase 4, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Licensure: new trials by email Literature Review of Licensure trials Research Report on Licensure

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Updated mRNA Seasonal Influenza Vaccines
mRNA-1010, Licensed High-Dose Seasonal Influenza Vaccine - Seasonal Influenza
Phase 4RecruitingModernaTX, Inc.2002026-10-152026-11-13
Multisite Observational Maternal and Infant Study for COVID-19
Licensed or EUA SARS-CoV-2 vaccine - COVID-19
CompletedEmory University5622021-07-062024-06-27
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
methotrexate(necessary), infliximab, etanercept - Rheumatoid Arthritis
Phase 4UnknownFen Li2402016-01-012016-08-25
A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents
H1N1 pandemic influenza vaccine (whole virion, Vero cell-derived, inactivated), Seasonal trivalent influenza vaccine (licensed) for the season 2010/2011 - Influenza, Pandemic Influenza
Phase 1 / Phase 2CompletedAlachua Government Services, Inc.4002009-09-012015-10-09

Conditions studied

Influenza, Human (2)  ·  Arthritis, Rheumatoid (1)  ·  Breast Feeding (1)  ·  COVID-19 (1)

Sponsors

Alachua Government Services, Inc. (1)  ·  Emory University (1)  ·  Fen Li (1)  ·  ModernaTX, Inc. (1)

Countries

United States (2)  ·  Austria (1)  ·  Germany (1)

Top investigators

Fen Li, doctor (1)  ·  Flor Munoz, MD (1)

Results publications

PMID 22846396, PMID 35734087, PMID 38332733

NIH funding

3UM1AI148576-02S5 (1)